Navigation Links
Genomes show how Staph bacteria gain resistance to last-line drug
Date:5/22/2012

National Institutes of Health-funded scientists have determined the genome sequences of a dozen strains of Staphylococcus aureus bacteria known to be resistant to vancomycin, an antibiotic of last resort. The researchers demonstrated -that resistance arose independently in each strain, and identified shared features among the strains that may have helped them acquire vancomycin resistance and evade human immune defenses.

Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of hospital-acquired infections in the United States, causing an estimated 18,000 deaths in 2005, the most recent data available. Severe multidrug-resistant MRSA infections require treatment with last-line antibiotics such as vancomycin. Since 2002, 12 cases of vancomycin-resistant S. aureus (VRSA) have been documented in the United States, raising concern that staph infections might become untreatable if vancomycin resistance became widespread. Most of the VRSA cases arose in people with diabetes who had limb infections characterized by the presence of multiple kinds of bacteria, including vancomycin-resistant Enterococcus bacteria.

By comparing the genetic differences among 12 VRSA strains available for study, the researchers found that the strains last shared a common ancestor more than 50 years ago, well before the emergence of vancomycin resistance. The gene sequences showed that rather than spreading from person to person, vancomycin resistance appeared anew in each VRSA case. The team found that each VRSA strain acquired a bit of genetic material called transposon Tn1546, which likely came from vancomycin-resistant Enterococcus bacteria that simultaneously infected the patients.

All the VRSA strains belong to the CC5 family, or clade, of Staphylococcus. The CC5 clade is usually found in antibiotic-resistant hospital-acquired staph infections. The genome data showed that CC5 clade strains lack the ability to make a natural antibacterial colonizing factor, which is why they can co-exist with Enterococcus. The study also revealed that CC5 strains make proteins that disrupt a variety of human immune responses and allow the bacteria to flourish, increasing the odds that resistance factors will be transferred from Enterococcus to Staphylococcus bacteria in a mixed infection.

The genomes provided clues as to why person-to-person spread of VRSA has not become common. Without the ability to make or resist the antibacterial colonizing factor, CC5 clade members are at a disadvantage in any encounter with other naturally occurring staph strains that normally live on the skin and that do produce this factor.


'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. Researchers Look at Genomes of Nonsmokers With Lung Cancer
2. Scientists Create First Monkeys With Mixed Genomes
3. International team to sequence genomes of fungi
4. Einstein researcher helps lead consortium for $10 million X Prize to sequence genomes of 100 centenarians
5. Orangutan Genomes Reveal Some Surprises
6. Punctuated evolution in cancer genomes
7. NIH-supported scientists investigate a newly emerging staph strain
8. Study Offers Update on Staph Pneumonia Trends in Children
9. Study finds livestock-related Staph strain in child care worker
10. Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide
11. Discovery of 2 new genes provides hope for stemming Staph infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: